Pharmacovigilance
EU + Switzerland, MENA, GCC, CIS, Australia, New Zealand & LATAM
More than ever, pharmacovigilance is a key issue in regulated markets. Safety and legislation are in the core of our philosophy. An experienced and fully dedicated team is always available for you and your patients.
- PSMF – Creation Review/Update
- Local QPPVs (Local Qualified Person for Pharmacovigilance) + Deputy
- Local Safety Officers
- Drug Safety Officers
- Local Literature Search
- Pharmacovigilance Training
- Pharmacovigilance Intelligence
- Data Management
- ICSR Eudravigilance: Download, conversion to XML and analysis
- XEVMPD – IDMP
- Audits
- Support on Inspections
- Support Assistance in Critical Findings
- CAPA preparation
In terms of Local QPPVs (Local Qualified Person for Pharmacovigilance), Drug Safety Officers (DSO) and Named Safety Contact (NSC), we cover the following countries:
Europe:
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic/Czechia
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
MENA/GCC:
- Algeria
- Bahrain
- Djibouti
- Egypt
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Libya
- Mauritania
- Morocco
- Oman
- Qatar
- Saudi Arabia
- Somalia
- Sudan
- Tunisia
- United Arab Emirates (UAE)
- Yemen
CIS:
- Armenia
- Azerbaijan
- Belarus
- Georgia
- Kazakhstan
- Kyrgyzstan
- Moldova
- Tajikistan
- Turkmenistan
- Ukraine
- Uzbekistan
OCEANIA:
- Australia
- New Zealand
LATAM:
- Argentina
- Bolivia
- Brazil
- Chile
- Colombia
- Costa Rica
- Dominican Republic
- Ecuador
- El Salvador
- French Guiana
- Guadeloupe
- Guatemala
- Haiti
- Honduras
- Martinique
- Mexico
- Nicaragua
- Panama
- Paraguay
- Puerto Rico
- Saint Barthélemy
- Saint Martin
- Uruguay
- Venezuela
If you are interested in further information, get in contact at info@abenora.com